Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	295301	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	327239	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	329421	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	331353	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	361400	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	390471	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	394750	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	398148	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	399118	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	404198	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	408792	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	417349	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	421061	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	424901	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	428775	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	429884	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	433613	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	434246	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	440164	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	442559	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	458067	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	464266	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	466692	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	466796	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	472148	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	473425	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	475370	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	478862	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	493632	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	504990	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	505290	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	505671	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	505793	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	516500	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	520510	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	524833	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	526240	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	546373	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	554637	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	557153	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	566834	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	572690	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	574745	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	580180	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	584544	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	584897	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	585192	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	588771	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	594542	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	597082	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	598466	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	601327	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	608354	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	613214	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	614421	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	615101	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	626918	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	627468	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	631151	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	636301	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	638681	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	639685	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	642673	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	645995	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	652095	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	652768	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	661184	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	667457	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	667882	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	676417	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	689297	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	691464	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	692088	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	702904	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	708373	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	711226	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	717209	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	722743	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	723877	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	724231	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	726148	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	729085	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	730973	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	739090	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	742157	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	745543	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	747080	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	772534	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	773132	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	778413	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	781178	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	784726	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	814013	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	822128	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	822426	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	822690	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	827439	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	853186	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	912917	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	URATE (CAS# 69-93-2); (M-H)-	914244	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	569119	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	583959	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	588861	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	611341	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	613354	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	624750	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	643295	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	650008	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	668258	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	669781	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	684603	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	710976	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	740398	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	776066	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	790880	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	815349	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	816153	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	819378	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	829633	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	838046	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	848193	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	857247	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	858364	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	869835	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	889494	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	890241	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	902101	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	908302	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	920436	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	928999	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	950322	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	973039	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	978045	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	981368	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	986006	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	986397	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	990275	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1002938	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1023870	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1024460	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1050735	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1053518	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1065891	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1077416	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1085960	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1097049	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1105004	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1106680	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1134373	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1135532	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1137375	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1139793	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1166201	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1177928	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1184082	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1184868	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1190613	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1194738	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1201941	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1211219	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1226445	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1226763	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1244004	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1262025	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1264869	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1271753	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1297626	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1314913	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1316575	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1322356	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1338730	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1342851	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1348821	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1380184	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1383975	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1395157	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1400996	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1446032	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1450028	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1464549	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1467550	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1478357	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1487666	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1513964	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1515325	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1529571	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1537470	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1572341	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1576630	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1643778	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1649656	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1652223	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1701031	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1737478	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1774521	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1833370	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1868218	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	1884562	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+	2226510	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	URATE (CAS# 69-93-2); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y

Return to search page